- Home
- UNP vs LLY Comparison
UNP vs LLY Comparison
Compare UNP & LLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UNP | LLY |
|---|---|---|
| Founded | 1862 | 1876 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Railroads | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 157.9B | 818.6B |
| IPO Year | 2004 | 2007 |
Fundamental Metrics
Financial Performance| Metric | UNP | LLY |
|---|---|---|
| Price | $252.26 | $921.15 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 23 | 19 |
| Target Price | $263.77 | ★ $1,217.79 |
| AVG Volume (30 Days) | ★ 2.4M | 2.3M |
| Earning Date | 04-23-2026 | 04-30-2026 |
| Dividend Yield | ★ 2.20% | 0.74% |
| EPS Growth | 8.03 | ★ 95.99 |
| EPS | 11.98 | ★ 22.95 |
| Revenue | $19,533,000,000.00 | ★ $65,179,000,000.00 |
| Revenue This Year | $4.68 | $26.98 |
| Revenue Next Year | $4.79 | $15.83 |
| P/E Ratio | ★ $20.99 | $40.52 |
| Revenue Growth | N/A | ★ 44.70 |
| 52 Week Low | $206.63 | $623.78 |
| 52 Week High | $268.14 | $1,133.95 |
Technical Indicators
Market Signals| Indicator | UNP | LLY |
|---|---|---|
| Relative Strength Index (RSI) | 61.95 | 43.52 |
| Support Level | $217.76 | $877.11 |
| Resistance Level | $268.14 | $1,102.49 |
| Average True Range (ATR) | 3.89 | 25.46 |
| MACD | 1.63 | 5.19 |
| Stochastic Oscillator | 96.75 | 44.23 |
Price Performance
Historical ComparisonAbout UNP Union Pacific Corporation
Omaha, Nebraska-based Union Pacific is the largest public railroad in North America. Operating on more than 30,000 miles of track in the western two-thirds of the US, Union Pacific generated $24 billion of revenue in 2024 by hauling coal, industrial products, intermodal containers, agricultural goods, chemicals, fertilizers, and automotive goods. Union Pacific owns about one-fourth of Mexican railroad Ferromex and historically derives roughly 10% of its revenue hauling freight to and from Mexico.
About LLY Eli Lilly and Company
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.